1. Opening Hook
Neogen’s Dahej plant caught fire months ago, but the real smoke this quarter came from delayed approvals and higher costs. Management says operations showed “resilience,” which is corporate-speak for we survived, barely. Revenue grew, margins expanded at the gross level, yet profits quietly tiptoed away.
The battery chemicals story, once pitched as a near-term rocket launch, is now waiting for PPAP stamps, policy clarity, and customer courage. Meanwhile, debt went up, insurance money is still on a scenic route, and FY26 guidance had to be gently walked back—again.
Still, the call wasn’t all doom. Japan tie-ups, non-FEOC buzzwords, and 2027 optimism were sprinkled generously. Management is clearly betting big on patience.
Read on—because the real action is not in Q2 numbers, but in what keeps getting pushed to “next year.”
2. At a Glance
- Revenue up 8% – Growth survived a plant fire; fire drills now part of SOP.
- Gross margin +350 bps – Raw material behaved, unlike everything else.
- EBITDA ₹30 cr – Looked decent until operating costs showed up uninvited.
- PAT ₹3 cr – Blink and you’ll miss it.
- Net debt ₹900 cr (consolidated) – Balance sheet doing heavy lifting.
- Battery revenue guidance cut to ₹30–40 cr – From moonshot to speed breaker.
3. Management’s Key Commentary
“Operational resilience defined our Q2 performance.”
(Plant burned, but we outsourced fast enough to keep the lights on. 😏)
“The Dahej outage was effectively neutralized.”
(Financials disagree slightly.)
“We expect insurance recovery including loss of profit in FY27.”
(Q2 and Q3, please manage on vibes and NCDs.)
“We may be the only Indian plant with PPAP approval for electrolyte.”
(Monopoly… once customers actually start producing batteries.)
“Salt approvals are provisional; final clearance expected by Jan–Feb 2026.”
(So, commercial sales: coming to a
